#VisualAbstract: Inebilizumab Improves Outcomes in Generalized Myasthenia Gravis
Click here to read this study in NEJM. ©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Tag: Inebilizumab
Inebilizumab reduces the risk of flares in IgG4-related disease
1. In this randomized controlled trial, inebilizumab, an anti-CD19 monoclonal antibody, reduced the risk of flares and increased the likelihood ...